Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Disease × Mitomycin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 32 Non-Muscle Invasive Bladder Neoplasms 21 Colorectal Neoplasms 16 Anus Neoplasms 15 Carcinoma, Transitional Cell 14 Carcinoma, Hepatocellular 11 Appendiceal Neoplasms 9 Stomach Neoplasms 8 Neoplasm Metastasis 8 Pancreatic Neoplasms 7 Carcinoma, Non-Small-Cell Lung 7 Peritoneal Neoplasms 6 Lung Neoplasms 5 Liver Neoplasms 5 Colonic Neoplasms 5 Rectal Neoplasms 4 Neoplasms 4 Carcinoma 4 Sarcoma 3 Recurrence 3 Pseudomyxoma Peritonei 3 Mesothelioma, Malignant 3 Gastrointestinal Neoplasms 3 Breast Neoplasms 3 Anal Canal Carcinoma 3 Uterine Cervical Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Ovarian Neoplasms 2 Head and Neck Neoplasms 2 Carcinoma in Situ 2

Interventions

Magnetic Resonance Spectroscopy 6 Blood Specimen Collection 6 Surveys and Questionnaires 5 Mammography 5 Colonoscopy 5 Magnetic Resonance Imaging 4 Dexamethasone 4 Cyclophosphamide 4 Biopsy, Fine-Needle 4 Tomography, X-Ray Computed 3 Prednisone 3 Positron Emission Tomography Computed Tomography 3 Melphalan 3 Liquid Biopsy 3 Lenalidomide 3 Interviews as Topic 3 Diagnostic Tests, Routine 3 Biopsy 3 weifuchun 2 pembrolizumab 2 fluciclovine F-18 2 daratumumab 2 Urination 2 Surgical Procedures, Operative 2 Preoperative Exercise 2 Positron-Emission Tomography 2 Methods 2 Injections 2 Immunohistochemistry 2 Gemcitabine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03335059 2020-04-15

RITE-USA

Medical Enterprises Ltd.

Phase 3 Terminated

Urinary Bladder Neoplasms, Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡